Blues highlight medical, benefit policy changes for Mar. 2012

Procedures for which BCBS Michigan is clarifying guidelines will appear under Policy Clarifications.

81228, 81229, S3870 Basic Benefit Policy Clarification
Genetic testing-array comparative genomic hybridization (ACGH) for the genetic evaluation of patients with developmental delay, mental retardation or autism spectrum disorder remains established. The policy was renamed to "Genetic Testing-Chromosomal Microarry (CMA) Analysis for the Genetic Evaluation of Patients with Developmental Delay/Intellectual Disability or Autism Spectrum Disorder." Additionally, procedure codes *81228 and *81229 were added to the policy as not payable, effective March 1, 2012.

SOURCE: Source
INDUSTRY NEWS TAGS: Blue Cross Blue Shield Michigan

Share This Post:

Search Billing News

Billing News By TAG

Billing News By DATE